50 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
Graham R. FosterChristophe HézodeOspedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy;J.‐P. BronowickiG. CarosiCharité -Campus Virchow Klinikum, Berlin, Germany;Ola WeilandOspedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy;Lieselotte VerlindenInstitute of Nuclear Medicine,Rolf van HeeswijkHeritage Medical Research Clinic -University of Calgary, Calgary, Alberta,Tony VangeneugdenCharité -Campus Virchow Klinikum, Berlin, Germany;Gastón PicchioCharité -Campus Virchow Klinikum, Berlin, Germany;Maria Beumont‐MauvielHospital Universitario Gaffree & Guinle, Rio de Janeiro, Brazil;
ABI
Abstract
No abstract available.
Topics
Identifiers
Citations and references
Cited by 00 references
Metrics — AkademScholar · Coming soon